Cisplatin trials for Pancreatic cancer
All Cisplatin trials · All Pancreatic cancer trials
9
Recruiting trials
Phase breakdown
Phase 1 4Phase 2 6Phase 3 1
Recruiting trials studying Cisplatin for Pancreatic cancer
- A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- AB122 Platform Study
- AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
- Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
- Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
- Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
- Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
- Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
Common questions
How many trials study Cisplatin for Pancreatic cancer?
9 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.